Two Rare Cases Of Central Nervous System Opportunistic Mycoses / Oportunističke Mikoze Središnjega Živčanog Sustava – Prikaz Dvaju Bolesnika

1. Pfaller MA, Diekema DJ. Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candidaalbicans and Aspergillus fumigatus. J Clin Microbiol 2004;42:4419-31.10.1128/JCM.42.10.4419-4431.200452236315472288Search in Google Scholar

2. Kutleša M, Mlinarić-Missoni E, Hatvani L, Vončina D, Šimon S, Lepur D, Baršić B. Chronic fungal meniongitis caused by Aureobasidium proteae. Diagn Microbiol Infect Dis 2012;73:271-2.10.1016/j.diagmicrobio.2012.03.00722504065Search in Google Scholar

3. Bolignano G, Criseo G. Disseminated nosocomial fungal infection by Aureobasidium pullulans var. melanigenum: a case Report. J Clin Microbiol 2003;41:4483-5.10.1128/JCM.41.9.4483-4485.200319386512958301Search in Google Scholar

4. Gunde-Cimerman N, Grube M, de Hoog GS. The emerging potential of melanized fungi: black yeast between beauty and the beast. Fungal Biol 2011;115:935-6.10.1016/j.funbio.2011.05.00321944204Search in Google Scholar

5. Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev 2010;23:884-928.10.1128/CMR.00019-10295298120930077Search in Google Scholar

6. Michael H, Robert R, Crystal S, Wendy V. Aureobasidiumpullulans infection: fungemia in an infant and a review of human cases. Diagn Microbiol Infect Dis 2005;51:209-13.10.1016/j.diagmicrobio.2004.10.00715766608Search in Google Scholar

7. Segal BH, Almyroudis NG, Battiwalla M, Herbrecht R, Perfect JR, Walsh TJ, Wingard JR. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. Clin Infect Dis 2007;44:402-9.10.1086/51067717205448Search in Google Scholar

8. Cafarchia C, Camarda A, Romito D, Campolo M, Quaglia NC, Tullio D, Otranto D. Occurrence of yeasts in cloacae of migratory birds. Mycopathologia 2006;161:229-34.10.1007/s11046-005-0194-z16552486Search in Google Scholar

9. Randhawa SH, Kowshik T, Chowdhary A, Sinha P, Khan UZ, Sun S, Xu J. The expanding host tree species spectrum for Cryptococcus gattii and Cryptococcus neoformans and their isolations from surrounding soil in India. Med Mycol 2008;46:823-33.10.1080/1369378080212402618608895Search in Google Scholar

10. Costa AK, Sidrim JJ, Cordeiro RA, Brilhante RS, Monteiro AJ, Rocha MF. Urban pigeons (Columba livia) as a potential source of pathogenic yeasts: a focus on antifungal susceptibility of Cryptococcus strains in Northeast Brazil. Mycopathologia 2010;169:207-13.10.1007/s11046-009-9245-119847668Search in Google Scholar

11. Perfect JR, Dismukes W E, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison T S, Larsen RA, Lortholary O, Nguyen MH, Pappas PG, Powderly WG, Singh N, Sobel JD, Sorrell TC. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases Society of America. Clin Infect Dis 2010;50:291-322.10.1086/649858582664420047480Search in Google Scholar

12. Park BJ, Wannemuehler KA, Marston B J, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009;23:525-30.10.1097/QAD.0b013e328322ffac19182676Search in Google Scholar

13. Mlinarić-Missoni E, Hagen F, Chew WHM, Važić-Babić V, Boekhout T, Begovac J. In vitro antifungal susceptibilities and molecular typing of sequentially isolated clinical Cryptococcus neoformans strains from Croatia. J Med Microbiol 2011;60:1487-95.10.1099/jmm.0.031344-021617022Search in Google Scholar

14. Murray PR, Rosenthal KS, Pfaller MA. Medical Microbiology. 6th ed. Philadelphia: Mosby Elsevier; 2009.Search in Google Scholar

15. de Hoog GS, Guarro J, Gene J, Figueras MJ. Atlas of Clinical Fungi. 4th ed. Utrecht: CBS; 2011.Search in Google Scholar

16. Anaissie EJ, Stratton SL, Dignani CM, Summerbell RC, Rex JH, Monson TP, Spencer T, Kasai M, Francesconi A, Walsh TJ. Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. Clin Infect Dis 2002;34:780-9.10.1086/33895811850861Search in Google Scholar

17. Dotis J, Panagopoulou P, Filioti J, Winn R, Toptsis C, Panteliadis C, Roilides E. Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease. Infection 2003;31:121-4.10.1007/s15010-002-2167-112682820Search in Google Scholar

18. Dotis J, Roilides E. Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature. Mycoses 2011;54:686-96.10.1111/j.1439-0507.2010.02001.x21615532Search in Google Scholar

19. Bukhari E, Alrabiaah A. First case of extensive spinal cord infection with Aspergillus nidulans in a child with chronic granulomatous disease. J Infect Dev Ctries 2009;3:321-3.10.3855/jidc.13219759498Search in Google Scholar

20. Segal BH, De Carlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine 1998;77:345-54.10.1097/00005792-199809000-000049772923Search in Google Scholar

21. Chakrabarti A, Marak RSK, Singhi S, Gupta S, Hurst SF, Padhye AA. Brain abscess due to Aspergillus nidulans. J Med Mycol 2006;16:100-4.10.1016/j.mycmed.2006.02.001Search in Google Scholar

22. Panigrahi A. Pediatric Osler-Weber-Rendu Syndrome [displayed 30 October 2012]. Available at http://emedicine.medscape.com/article/957067-overviewSearch in Google Scholar

23. Dornbusch HJ, Groll A, Walsh TJ. Diagnosis of invasive fungal infections in immunocompromised children. Clin Microbiol Infect 2010;16:1328-34.10.1111/j.1469-0691.2010.03336.x20678175Search in Google Scholar

24. Espinel-Ingroff A, Johnson E, Hockey H, Troke P. Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole. Phase III clinical studies. J Antimicrob Chemother 2008;61:616-20. 10.1093/jac/dkm51818222957Search in Google Scholar